Oncovin

(redirected from vincristine sulfate)
Also found in: Thesaurus, Medical, Financial, Encyclopedia.
Related to vincristine sulfate: Oncovin
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Oncovin - periwinkle plant derivative used as an antineoplastic drug (trade name Oncovin); used to treat cancer of the lymphatic system
periwinkle plant derivative - an antineoplastic drug used to treat some forms of cancer
brand, brand name, marque, trade name - a name given to a product or service
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
and its affiliates for which CASI has exclusive rights to the greater China market, consisting of EVOMELA (Melphalan for Injection), ZEVALIN (Ibritumomab Tiuxetan) and MARQIBO (Vincristine Sulfate Liposome Injection) and (iv) a portfolio of FDA-approved and pending abbreviated new drug applications (ANDAs), including entecavir and tenofovir disoproxil fumarate (TDF) indicated for the treatment of hepatitis B virus.
and its affiliates for which CASI has exclusive rights to the greater China market, consisting of EVOMELA[R] (Melphalan for Injection), ZEVALIN[R] (Ibritumomab Tiuxetan) and MARQIBO[R] (Vincristine Sulfate Liposome Injection); and (iv) a portfolio of FDA-approved and pending abbreviated new drug applications (ANDAs), including entecavir and tenofovir disoproxil fumarate (TDF) indicated for the treatment of hepatitis B virus.
has approved the company's Clinical Trial Application allowing for a registration clinical trial to evaluate the efficacy and safety of vincristine sulfate Liposome injection, Marqibo.
Under the deal, Acrotech will acquire products including Fusilev (levoleucovorin), Folotyn (pralatrexate injection), Zevalin (ibritumomab tiuxetan), Marqibo (vinCRIStine sulfate Liposome injection), Beleodaq (belinostat) for injection, Evomela (melphalan) for injection and Khapzory (levoleucovorin).
Under the sale, the seven US FDA-approved hematology/oncology products include: FUSILEV (levoleucovorin), FOLOTYN (pralatrexate injection), ZEVALIN (ibritumomab tiuxetan), MARQIBO (vinCRIStine sulfate LIPOSOME injection), BELEODAQ (belinostat) for injection, EVOMELA (melphalan) for injection, and KHAPZORY (levoleucovorin).
In the third-line treatment 4 (22%) out of 18 patients were treated with ifosfamide-based regimen, 8 (44.4%) received one of CHOP-like regimens, 3 (16.6%) platinum-based regimen, while 2 (11.1%) received cyclophosphamide, vincristine sulfate, adriamycin, dexamethasone (hyper CVAD).